🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the recommended dose of CMC544 ad...
Status
Completed
Location
AZ Sint Jan
Start Date
2012-12
Trial ID
NCT01562990
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
This randomized phase II trial studies how well high or standard intensity ...
Status
Terminated
Location
Kaiser Permanente Oakland-Broadway
Start Date
2013-08
Trial ID
NCT01921751
The combination of chemotherapy with radiotherapy remains the standard of t...
Status
Terminated
Location
University Hospital of Crete
Start Date
2006-03
Trial ID
NCT00431613
Treatments Being Tested
This study will look to see how well patients with relapsed or recurrent in...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2010-08
Trial ID
NCT01270724
Treatments Being Tested
The objective of the study is evaluation of efficacy of Bendamustine, Gemcy...
Status
Completed
Location
Oddział Kliniczny Onkologii, Centrum Onkologii im. Prof. F. Łukaszczyka
Start Date
2017-11-06
Trial ID
NCT03615664
Treatments Being Tested
This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin ...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2017-12-05
Trial ID
NCT03366272
Treatments Being Tested
This study examines the use of denileukin diftitox (Ontak) for patients wit...
Status
Terminated
Location
Washington University
Start Date
2008-07-01
Trial ID
NCT00632827
This trial investigates the efficacy and safety of the drug tislelizumab in...
Status
Active Not Recruiting
Location
BE-Bruxelles-STLUC
Start Date
2023-07-14
Trial ID
NCT05502250
Treatments Being Tested
This is a phase III randomized study comparing induction treatments of Gemc...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-10
Trial ID
NCT00191646
Treatments Being Tested